在成年人中,相对血小板细胞和微蛋白尿之间的关联与轻度禁食高血糖症
Jong Wook Choi1, Tae Hoon Kim2, Joon-Sung Park3
1Research Institute of Medical Science, Konkuk University School of Medicine, Chungju 27478, Republic of Korea.
Journal of personalized medicine
|January 22, 2024
概括
血小板数量升高,即使低于诊断水平,也与患有禁食葡萄糖受损的人群中微血管并发症风险增加有关. 这表明血小板在糖尿病损伤中可能发挥作用.
科学领域:
- 内分泌学 在内分泌学.
- 血液学 血液学 血液学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 血小板数升高与血栓事件和糖尿病微血管并发症有关.
- 糖尿病的标志物白尿与内皮功能障碍有关.
研究的目的:
- 在健康成年人中,研究相对血栓塞动症与尿中白蛋白与肌素比率增加之间的关联.
- 在葡萄糖代谢的背景下,探索血小板计数和内皮功能障碍标志物之间的关系.
主要方法:
- 对12525名韩国成年人的数据进行了多变量分析 (韩国国家健康和营养检查调查V-VI).
- 参与者按性别分为血小板计数五分之一.
- 限制立方线回归和调整后勤回归模型用于评估关联.
主要成果:
- 发现了血小板数和空腹血糖,糖化血红蛋白和尿液中白蛋白与肌素的比率之间的显著关联.
- 禁食血糖和血小板数量增加与微专尿风险有关 (分别为OR=1.026和OR=1.004).
- 血小板数量的增加与患有禁食葡萄糖受损的受试者中微专尿症进展显著相关.
结论:
- 血小板数量升高,即使低于诊断性血栓细胞瘤水平,也与血管内皮功能障碍风险增加独立相关,在患有禁食葡萄糖受损的个体中.
- 这些发现凸显了血小板数量升高在糖尿病微血管并发症的发病过程中的潜在作用.
更多相关视频
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
546
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
546
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Hypoglycemia and Glucagon
263
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
263
Glucose Transporters
22.8K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.8K
Oral Hypoglycemic Agents: Biguanides and Glitazones
204
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
204
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K


